{"id":323,"date":"2025-04-27T03:16:32","date_gmt":"2025-04-27T03:16:32","guid":{"rendered":"https:\/\/blog.adlington.fr\/index.php\/2025\/04\/27\/comment-les-traitements-anticancereux-font-la-fortune-des-laboratoires-pharmaceutiques\/"},"modified":"2025-04-27T03:16:32","modified_gmt":"2025-04-27T03:16:32","slug":"comment-les-traitements-anticancereux-font-la-fortune-des-laboratoires-pharmaceutiques","status":"publish","type":"post","link":"https:\/\/blog.adlington.fr\/index.php\/2025\/04\/27\/comment-les-traitements-anticancereux-font-la-fortune-des-laboratoires-pharmaceutiques\/","title":{"rendered":"Comment les traitements anticanc\u00e9reux font la fortune des laboratoires pharmaceutiques"},"content":{"rendered":"<blockquote><p>Chaque ann\u00e9e, plus de 20&nbsp;millions de nouveaux cas sont diagnostiqu\u00e9s \u00e0 travers la plan\u00e8te, rapporte l\u2019Organisation mondiale de la sant\u00e9. Avec un d\u00e9c\u00e8s sur six qui lui est attribu\u00e9, le cancer est ainsi la deuxi\u00e8me cause de mortalit\u00e9 dans le monde, derri\u00e8re les maladies cardiovasculaires. En France, c\u2019est m\u00eame l\u2019ennemi public num\u00e9ro un, 25&nbsp;% des d\u00e9c\u00e8s annuels lui \u00e9tant dus.<br \/>\n\u2014 Read on <a href=\"https:\/\/www.lemonde.fr\/economie\/article\/2025\/04\/26\/comment-les-traitements-anticancereux-font-la-fortune-des-laboratoires-pharmaceutiques_6600182_3234.html\">www.lemonde.fr\/economie\/article\/2025\/04\/26\/comment-les-traitements-anticancereux-font-la-fortune-des-laboratoires-pharmaceutiques_6600182_3234.html<\/a><\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Chaque ann\u00e9e, plus de 20&nbsp;millions de nouveaux cas sont diagnostiqu\u00e9s \u00e0 travers la plan\u00e8te, rapporte l\u2019Organisation mondiale de la sant\u00e9. Avec un d\u00e9c\u00e8s sur six qui lui est attribu\u00e9, le cancer est ainsi la deuxi\u00e8me cause de mortalit\u00e9 dans le monde, derri\u00e8re les maladies cardiovasculaires. En France, c\u2019est m\u00eame l\u2019ennemi public num\u00e9ro un, 25&nbsp;% des [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-323","post","type-post","status-publish","format-standard","hentry","category-blog"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/posts\/323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/comments?post=323"}],"version-history":[{"count":0,"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/posts\/323\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/media?parent=323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/categories?post=323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.adlington.fr\/index.php\/wp-json\/wp\/v2\/tags?post=323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}